|
| |
| | | | 1 | | | DO1.PCCNTR.2019948 ContractData Container |
| | | 1.1 | | | | | | | | | | 1,196,884,675.00 | 0.00 | 0.00 | 0.00 | 1,182,040,100.00 | 1,196,884,675.00 |
|
| | | | | | | 1 | | 2.3.4.1.01 | Cetuximab 5 mg/ ml | 1,894 | UD | 29,600 | 31,000 | 58,714,000.00 | | 0.00 | | | 0.00 | | 0.00 | 56,062,400.00 | 58,714,000.00 | |
|
| | | | | | | 2 | | 2.3.4.1.01 | Emicizumab 30 mg /1 ml | 570 | UD | 117,000 | 117,000 | 66,690,000.00 | | 0.00 | | | 0.00 | | 0.00 | 66,690,000.00 | 66,690,000.00 | |
|
| | | | | | | 3 | | 2.3.4.1.01 | Emicizumab 105 mg /0.7 ml | 1,670 | UD | 400,000 | 400,000 | 668,000,000.00 | | 0.00 | | | 0.00 | | 0.00 | 668,000,000.00 | 668,000,000.00 | |
|
| | | | | | | 4 | | 51201569 - Atlizumab o to(...)51201569 - Atlizumab o tocilizumab |
| 2.3.4.1.01 | Ocrelizumab 300 mg/ 10 ml | 421 | UD | 441,000 | 459,175 | 193,312,675.00 | | 0.00 | | | 0.00 | | 0.00 | 185,661,000.00 | 193,312,675.00 | |
|
| | | | | | | 5 | | 51201569 - Atlizumab o to(...)51201569 - Atlizumab o tocilizumab |
| 2.3.4.1.01 | Pertuzumab 600 mg / Trastuzumab 600 mg | 430 | UD | 234,000 | 234,000 | 100,620,000.00 | | 0.00 | | | 0.00 | | 0.00 | 100,620,000.00 | 100,620,000.00 | |
|
| | | | | | | 6 | | 51201569 - Atlizumab o to(...)51201569 - Atlizumab o tocilizumab |
| 2.3.4.1.01 | Trastuzumab 600 mg | 696 | UD | 65,200 | 68,000 | 47,328,000.00 | | 0.00 | | | 0.00 | | 0.00 | 45,379,200.00 | 47,328,000.00 | |
|
| | | | | | | 7 | | 2.3.4.1.01 | Cladribina 10 mg | 305 | UD | 195,500 | 204,000 | 62,220,000.00 | | 0.00 | | | 0.00 | | 0.00 | 59,627,500.00 | 62,220,000.00 | |
|
|
| | | |
| | | |
|